Table 3 Comparison between the cohorts regarding intraoperative, postoperative parameters, and erectile function status
Group I | Group II | p-value | |
|---|---|---|---|
Operative time (min) | 140.3 ± 36.3 | 151.9 ± 4.7 | < 0.001 |
Hospital stays (days) | 3.24 ± 0.75 | 3.55 ± 0.78 | 0.004 |
Catheter duration (weeks) | 2.9 ± 0.98 | 3.23 ± 0.4 | < 0.001 |
Post-operative complications | 0.69 | ||
Wound infection, n (%) Perineal hematoma, n (%) orchitis, n (%) | 5 (6.8%) 1 (1.3%) 0 | 8 (4.7%) 2 (1.2%) 2 (1.2%) | |
Post-operative IPSS | 4.97 ± 5.59 | 4.28 ± 4.32 | 0.29 |
Post-operative Q-max | 21.88 ± 5.8 | 22.4 ± 6.3 | 0.54 |
Follow up period (months) | 44.29 ± 17.26 | 47.6 ± 22.2 | 0.25 |
Urethroplasty success, n (%) | 65 (87.8%) | 148 (86.5%) | 0.93 |
Pre-operative IIEF | 26.12 ± 1.7 | 26.28 ± 1.87 | 0.4 |
Preoperative ED, n (%) | 11 (14.9%) | 20 (11.7%) | 0.38 |
IIEF,3-months postoperative | 24.5 ± 2.8 | 26.11 ± 2.68 | < 0.001 |
Transient ED, n (%) | 6 (8.1%) | 5 (2.9%) | 0.07 |
IIEF,12-months postoperative | 26.24 ± 2.5 | 26.29 ± 2.47 | o.8 |
Permanent ED, n (%) | 3 (4.1%) | 5 (2.9%) | 0.65 |